170 related articles for article (PubMed ID: 29804370)
1. [Review and prospect of clinical study on liver transplantation of hepatocellular carcinoma].
Huang XW; Zhou J
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):81-83. PubMed ID: 29804370
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Skibba A; Kam I
Liver Transpl; 2008 May; 14(5):633-8. PubMed ID: 18324656
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.
Schnitzbauer AA; Zuelke C; Graeb C; Rochon J; Bilbao I; Burra P; de Jong KP; Duvoux C; Kneteman NM; Adam R; Bechstein WO; Becker T; Beckebaum S; Chazouillères O; Cillo U; Colledan M; Fändrich F; Gugenheim J; Hauss JP; Heise M; Hidalgo E; Jamieson N; Königsrainer A; Lamby PE; Lerut JP; Mäkisalo H; Margreiter R; Mazzaferro V; Mutzbauer I; Otto G; Pageaux GP; Pinna AD; Pirenne J; Rizell M; Rossi G; Rostaing L; Roy A; Turrion VS; Schmidt J; Troisi RI; van Hoek B; Valente U; Wolf P; Wolters H; Mirza DF; Scholz T; Steininger R; Soderdahl G; Strasser SI; Jauch KW; Neuhaus P; Schlitt HJ; Geissler EK
BMC Cancer; 2010 May; 10():190. PubMed ID: 20459775
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review.
Cholongitas E; Mamou C; Rodríguez-Castro KI; Burra P
Transpl Int; 2014 Oct; 27(10):1039-49. PubMed ID: 24943720
[TBL] [Abstract][Full Text] [Related]
5. Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantation.
Chen K; Man K; Metselaar HJ; Janssen HL; Peppelenbosch MP; Pan Q
Liver Transpl; 2014 Mar; 20(3):261-9. PubMed ID: 24376158
[TBL] [Abstract][Full Text] [Related]
6. Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series.
Ferreiro AO; Vazquez-Millán MA; López FS; Gutiérrez MG; Diaz SP; Patiño MJ
Transplant Proc; 2014 Dec; 46(10):3496-501. PubMed ID: 25498079
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.
Saab S; McTigue M; Finn RS; Busuttil RW
Exp Clin Transplant; 2010 Dec; 8(4):307-13. PubMed ID: 21143097
[TBL] [Abstract][Full Text] [Related]
8. Strategies of immunosuppression for liver transplant recipients with hepatocellular carcinoma.
Castroagudín JF; Molina-Pérez E; Ferreiro-Iglesias R; Varo-Pérez E
Transplant Proc; 2011 Apr; 43(3):711-3. PubMed ID: 21486580
[TBL] [Abstract][Full Text] [Related]
9. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.
Rodríguez-Perálvarez M; Tsochatzis E; Naveas MC; Pieri G; García-Caparrós C; O'Beirne J; Poyato-González A; Ferrín-Sánchez G; Montero-Álvarez JL; Patch D; Thorburn D; Briceño J; De la Mata M; Burroughs AK
J Hepatol; 2013 Dec; 59(6):1193-9. PubMed ID: 23867318
[TBL] [Abstract][Full Text] [Related]
10. [Liver transplantation for hepatocellular carcinoma and potential application of PSI].
Decaens T; Duvoux C
Gastroenterol Clin Biol; 2009 Nov; 33 Suppl 4():S257-62. PubMed ID: 20004332
[TBL] [Abstract][Full Text] [Related]
11. The impact of mTOR inhibitors on the development of malignancy.
Geissler EK
Transplant Proc; 2008 Dec; 40(10 Suppl):S32-5. PubMed ID: 19100904
[TBL] [Abstract][Full Text] [Related]
12. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for hepatocellular carcinoma: an update.
Zarrinpar A; Kaldas F; Busuttil RW
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):234-42. PubMed ID: 21669564
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation.
Gomez-Martin C; Bustamante J; Castroagudin JF; Salcedo M; Garralda E; Testillano M; Herrero I; Matilla A; Sangro B
Liver Transpl; 2012 Jan; 18(1):45-52. PubMed ID: 21932373
[TBL] [Abstract][Full Text] [Related]
15. [The mechanism and current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation].
Wang HQ; Li L; Yang JY
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):93-97. PubMed ID: 29804373
[TBL] [Abstract][Full Text] [Related]
16. Managing access to liver transplantation: implications for gastroenterology practice.
Brown R; Emond JC
Gastroenterology; 2007 Mar; 132(3):1152-63. PubMed ID: 17383434
[No Abstract] [Full Text] [Related]
17. Use of everolimus in liver transplantation: The French experience.
Dumortier J; Dharancy S; Calmus Y; Duvoux C; Durand F; Salamé E; Saliba F
Transplant Rev (Orlando); 2016 Jul; 30(3):161-70. PubMed ID: 27083870
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.
Fahrner R; Dondorf F; Ardelt M; Dittmar Y; Settmacher U; Rauchfuß F
World J Gastroenterol; 2015 Nov; 21(42):12071-82. PubMed ID: 26576092
[TBL] [Abstract][Full Text] [Related]
19. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
[TBL] [Abstract][Full Text] [Related]
20. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?
Castroagudín JF; Molina-Pérez E; Ferreiro-Iglesias R; Abdulkader I; Otero-Antón E; Tomé S; Varo-Pérez E
Transplant Proc; 2012; 44(6):1565-7. PubMed ID: 22841215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]